AWA Point
Author: Niklas Mattsson
Is 1 April 2023 the date for entry into force of the Unitary Patent?
On 6 October, the UPC Preparatory team published information that they are currently planning for entry into force of
Are you ready for the Unitary Patent?
The Unitary Patent and the Unified Patent Court will significantly impact the patent system in Europe. For applicants or
Was this the last hurdle for German UPCA Ratification?
At the end of 2020, German ratification of the Agreement on a Unified Patent Court (UPCA) looked promising as
Patenting Antibody and Cell Therapies – What to Do and What Not to Do
Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great
German Court finds Unified Patent Court legislation unconstitutional
Today, the court tasked with upholding Germany’s constitution, the Bundesverfassungsgericht, has issued its long-awaited decision on a complaint against
UK is out of the Unified Patent Court
The United Kingdom’s government has confirmed to industry publication IAM-Media that the country will not be a member of
German decision on UPC expected in early 2020
In an interview with IP industry publication Managing IP, Justice Huber of the German Federal Constitutional Court stated that
Unitary SPCs in Europe after all?
As readers of this blog know, we at Awapatent are actively following the exciting developments in the creation of
Myriad patent claims on breast cancer genes invalidated by US Supreme Court
In a decision on 13 June, the highest court of the USA, the US Supreme Court, said the final
Breast cancer gene patents once again found valid by US appeals court
In the “Myriad case” an ongoing legal battle with many twists and turns, the Court of Appeals for the